Stay informed with the latest updates for the inheritable blood disorders community.

          Medical
          Birth control pills
          FDA Approves First-Ever Nonprescription Oral Contraceptive
          NBDF & Community
          Peggy, a longtime community member shares her family's history of involvement and advocacy.
          A Longtime Legacy
          Advocacy & Legislative
          Government Relations Update - April 2023
          Government Relations Update - June 2023
          Industry
          Clinical Trial Lab Research
          New Trial Data Shows ALTUVIIIO™ Prophylaxis Effective in Children
          Industry
          FDA Approval
          Hemophilia A Gene Therapy Product Receives U.S. FDA Approval
          Medical
          Doctor and patient
          Patient-Clinician Partnerships the Theme of ASCO Presidential Address
          Industry
          First Hemophilia B Patient Dosed with Gene Therapy Product
          NBDF & Community
          Shaping the Future: Search Begins for New NHF CEO
          Shaping the Future: Search Begins for New NHF CEO
          Peer-Reviewed Journal Summaries
          Biomarin Provides Hemophilia A Clinical Development Program Updates
          Inequities in Thrombosis and Hemostasis Lab Testing the Focus of…
          Peer-Reviewed Journal Summaries
          FDA Places Clinical Hold on Sigilon’s Investigational Hemophilia Therapy
          Gene Therapy as a Novel Approach to Achieving ITI in FVIII Inhibitors…
          NBDF & Community
          The King Years: A Legacy Continues
          Advocacy & Legislative
          Government Relations Update
          Government Relations Update - May 2023
          Industry
          Research Blood Disorder Vial
          Pfizer Highlights Phase 3 Trial Results of Marstacimab
          NBDF & Community
          Dr. Valentino Becomes CEO
          Announcement from NHF CEO and President
          NBDF & Community
          It is Family: A Conversation with Saylor Behrens